XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows provided by (used in) operating activities:    
Net income (loss) $ 1,356 $ (853)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:    
Gain from sale of OSP (Note 3) 0 (957)
Depreciation and amortization 758 425
Deferred income taxes 462 (221)
Non-cash interest 1,404 1,264
Gain on earn-out liability (1,000) 0
Long lived asset impairment 0 352
Stock-based compensation 629 1,430
Amortization of debt discount and financing costs 906 719
Other non-cash items affecting earnings 198 (80)
Ad fund 1,069 2,840
Changes in operating assets and liabilities [1] (3,499) (6,263)
Net cash provided by (used in) operating activities 2,283 (1,344)
Cash flows (used in) provided by investing activities:    
Capital expenditures (395) (16)
Proceeds from sale of OSP, net of fees 0 957
Net cash (used in) provided by investing activities (395) 941
Cash flows (used in) provided by financing activities:    
Borrowings on revolving credit facility 0 4,326
Repayments of revolving credit facility 0 (10,237)
Repayments of long-term debt (1,840) (263)
Debt refinancing fees (8) (298)
Proceeds from issuance of common stock, net of offering costs 589 0
Taxes paid for shares withheld (19) (23)
Net cash used in financing activities (1,278) (6,495)
Effect of exchange rate changes on cash and cash equivalents (48) 27
Increase (decrease) in cash, cash equivalents, and restricted cash 562 (6,871)
Cash, cash equivalents and restricted cash:    
Beginning of period 35,205 29,312
End of period $ 35,767 $ 22,441
[1] Changes in operating assets and liabilities exclude ad fund and assets and liabilities sold or acquired.